Inactivation of both alleles of the fruit¯y D. melanogaster brain tumor (brat) gene results in the production of a tumor-like neoplasm in the larval brain, and lethality in the larval third instar and pupal stages. We cloned the brat gene from a transposon-tagged allele and identi®ed its gene product. brat encodes for an 1037 amino acid protein with an N-terminal B-box1 zinc ®nger followed by a B-box2 zinc ®nger, a coiled-coil domain, and a C-terminal b-propeller domain with six blades. All these motifs are known to mediate protein ± protein interactions. Sequence analysis of four brat alleles revealed that all of them are mutated at the bpropeller domain. The clustering of mutations in this domain strongly suggests that it has a crucial role in the normal function of Brat, and de®nes a novel protein motif involved in tumor suppression activity. The brat gene is expressed in the embryonic central and peripheral nervous systems including the embryonic brain. In third instar larva brat expression was detected in the larval central nervous system including the brain and the ventral ganglion, in two glands ± the ring gland and the salivary gland, and in parts of the foregut ± the gastric caecae and the proventriculus. A second brat-like gene was found in D. melanogaster, and homologs were identi®ed in the nematode, mouse, rat, and human. Accumulated data suggests that Brat may regulate proliferation and dierentiation by secretion/transportmediated processes.
Introduction
Genetic analysis in Drosophila has shown that neoplasm may arise from inactivation of more than 50 genes controlling cell proliferation, growth and dierentiation. The tumors are found in the embryo, the larva, and in the adult¯y, aecting cells and tissues such as the blood cells, the imaginal discs, the neuroblasts in the larval brain, and the adult gonial cells. They are characterized by loss of capacity for dierentiation and rapid growth in situ as well as after transplantation. In recent years, many of these tumor suppressor genes have been cloned, and most have homologs in mammals (Gate, 1978a,b; Mechler, 1994; Watson et al., 1994; Gate et al., 1996; Potter et al., 2000) . Recently it has been shown that mice in which the Drosophila tumor suppressor lats homolog was knocked out develop soft-tissue sarcomas and ovarian stromal cell tumors and are highly sensitive to carcinogenic treatments (St. John et al., 1999) . Recessive mutations in at least four of the Drosophila tumor suppressor genes disc large (dlg), lethal giant larvae (lgl), malignant brain tumor (mbt) and brain tumor (brat), lead to identical phenotypes, namely malignant neoplasm in the presumptive adult optic centers in the larval brain. In these mutants, the optic neuroblasts and the ganglion mother cells fail to dierentiate into adult optic neurons. These cells continue to grow and subsequently invade the region of the larval neurons and the neuropile, destroying the normal brain structure. Small pieces of mutant brain that are implanted into the abdominal cavity of female adult¯ies grow rapidly and spread throughout the body cavity, invading normal tissues and organs (Gate, 1978b) . Clonal analysis suggest that these brain tumors arise from only a few hundred cells in the mutant brains, comprising 1 ± 2% of total brain cells (Woodhouse et al., 1998) . Accumulation of type IV collagenase, an enzyme associated with many human tumors, was observed in tumors derived from lgl mutant brains (Woodhouse et al., 1994) .
Dlg is localized at the lateral contacts between cells at the septate junctions, an invertebrate-speci®c junction that could be the functional homolog of the vertebrate tight junction (Bryant, 1997) . A human homologue of Dlg, HDLG, binds directly to the 4.1 protein and to the product of the APC tumor suppressor gene (Lue et al., 1994; Matsumine et al., 1996) . The later complex negatively regulates progression of the cell cycle from G0/G1 to S phase (Ishidate et al., 2000) . The Lgl protein is bound to the inner surface of lateral cell membranes in regions of cell junctions, and it is present in high molecular weight aggregates (Strand et al., 1994a,b) . Lgl mouse homolog, Mgl-1, is a possible target for the product of a Hox gene (Tomotsune et al., 1993) . Mbt is a prolinerich nuclear protein with a novel zinc ®nger (Wismar et al., 1995) . It belongs to the Polycomb group (PcG) protein family and may be involved in regulation of speci®c genes by changing the chromatin structure. Its human homolog completely associates with condensed chromosomes in mitotic cells, and may play a role in proper progression of cell division (Koga et al., 1999) .
brat, also termed lethal(2)37Cf, was ®rst identi®ed in 1976, during a screen for lethal mutations in the dopa decarboxylase region (Wright et al., 1976 (Wright et al., , 1981 . It is located on chromosome 2 at 37C6 ± 7 (Wright et al., 1981; Spradling et al., 1999) . Several brat alleles were isolated. Surviving heteroallelic heterozygotes of incompletely lethal alleles demonstrate variable amounts of male and female sterility and incompletely sclerotized cuticle (Stathakis et al., 1995; Wright, 1996) . In several lethal alleles the brain hemispheres are much enlarged, while the ventral ganglion and the imaginal discs appear normal (Figures 1 and 7a,b) . Histological analysis indicated that brain overgrowth is limited to the optical centers, stemming from uncontrolled divisions of the optic neuroblasts and the ganglion mother cells (Kurzik-Dumke et al., 1992; Gate et al., 1993) . brat mutated brains can reach a size 10 times larger than their normal counterparts. The transformed neuroblasts can grow not only in situ, but also in vivo, after transplantation into abdomens of adult female¯ies. The transplanted neuroblasts grow rapidly, forming metastases and secondary malignant tumors, and ®nally kill their host. brat imaginal discs, in spite of their normal phenotype, can also form metastases and secondary tumors in vivo (Woodhouse et al., 1998) .
In this work we describe the cloning of the brat gene, the structure of its RNA and protein products, the characterization of brat expression pattern during development, and the identi®cation of the protein motif associated with brat tumor suppression activity.
Results

Reverting the brat phenotype by tranposon excision
To ascertain unambiguous identi®cation of the brat gene, we cloned it from two P-element strains, l(2)K06028 and l(2)K11523, obtained by a single Pelement insertional mutagenesis of the second chromosome of D. melanogaster (ToÈ roÈ k et al., 1993; Spradling et al., 1999) . Strains homozygous for these insertions manifest a strong brat phenotype, and the mutations were termed brat K06028 and brat
K11523
, respectively. A third brat P-element strain, l(2)K11538, is probably a duplicate of strain l(2)K11523 (Spradling et al., 1999) since both were obtained from the same parents and may be derived from a premeiotic cluster. We veri®ed that each strain carries only one P-element used in the mutagenesis experiment (the P-lacW transposon, Bier et al., 1989) , by restricting genomic DNA from these strains with enzymes that cut once within the transposon, and once in the adjacent genomic DNA. Under these conditions, restriction of transposons inserted in dierent sites yielded distinct restriction fragments, as predicted by the detailed map of the brat region (Figure 2a ; data not shown). If the brat mutation is caused by the inserted P-lacW, excision of the transposon should result in viable revertants. Indeed, excising the transposon in brat K06028 produced a number of viable, fertile revertant strains.
The brat locus
The brat gene was cloned by the plasmid rescue approach. Genomic DNA from the P-element strains was cut with restriction enzymes that cut once within the P-element sequence, the restricted DNA was circularized, and DNA clones made of the P-element DNA fused to adjacent genomic DNA were isolated. The genomic DNA was sequenced, and overlapping sequences from public databases were identi®ed and compiled with the excised sequences to generate a continuous brat DNA locus. In order to construct a transcription map, an embryonic cDNA library was screened with a brat probe made of sequences obtained by the excision procedure, and over 30 clones were identi®ed. Additional nine brat expressed sequence tags (EST) clones were identi®ed in public databases. By comparison of this information with the genomic sequences, a brat gene organization map was compiled (Figure 2a ). The brat gene spans more than 38 000 base pairs. The gene is made up of at least ®ve exons and four introns, where the exact starting point of the putative ®rst exon is still unclear. The coding region is con®ned to exon 5 only. Sequence analysis of the 5'-ends of the cDNA and EST clones reveals two cDNA types: those including exons 1, 2, 4 and 5, and those including exons 3, 4 and 5. From the ®rst group we found three independent isolates starting within a segment of 51 bases (nucleotides 1, 46 and 51, respectively; Figure 2a) . From the second group we found three independent isolates starting within a Figure 1 Figure 2a ). Consequently, we suggest that brat codes for two transcripts, each of them should have its own independent promoter (Figure 2b ). The P-element in brat k06028 was found to be inserted in exon 4 after nucleotide 32500, whereas the P-element in brat k11523 is inserted at intron IB after nucleotide 26113 (Figure 2a) . A D. melanogaster transposon 297 (a copialike element; Inouye et al., 1986) was found in the sequence of the D. melanogaster prototype genome, in the middle of intron B. Since the stock being used for the Drosophila Genome Project is a wild-type, viable stock, we infer that this transposon is neutral and has no recognized eect on the¯ies that carry it.
The brat protein
The derived amino acid sequence of Brat indicates a protein of 1037 amino acids containing runs of glutamine, serine, alanine, histidine, glycine, and leucine. The brat protein was analysed for conserved motifs and was found to contain two B-box zinc-®nger motifs, a coiled-coil domain, and a b-propeller domain ( Figure  3a ,b). All these motifs are reported to be involved in protein ± protein interactions. The B-box domains of Brat are of type 1 and 2, respectively (Reddy et al., 1992) . Both are made of 34 amino acids, and are separated by 115 amino acids. The Brat coiled-coil domain is 136 amino acids long (Lupas, 1996) . It is located immediately after the B box domains, similarly to several other B boxcontaining proteins (Reddy et al., 1992) . The C-terminus region of Brat consists of a b-propeller domain made of six NHL repeats (®rst identi®ed in three proteins, Ncl-1, HT2A and LIN-41; Slack and Ruvkun, 1998) . Each repeat is about 44 amino acids, rich in glycine and hydrophobic residues, and contains a cluster of charged residues near its C-terminal end. The variable Nterminal portion of each repeat would be displayed on the outer surface of each blade and provide sites for protein ± protein interactions. The amino acid sequence of the Brat C-terminal repeats is highly similar to the NHL consensus repeat (Figure 3c ).
The brat gene family
We searched the databases for proteins containing all three motifs together, namely B-boxes (or related zinc ®ngers), coiled-coil, and b-propeller. A number of proteins, from the nematode to human, were found. They are shown in descending order according to their homology with Brat b-propeller domain (Figure 4a ), and grouped herein according to the number and type of the zinc ®ngers present. Most similar to Brat is the nematode C. elegans Ncl-1 protein. Ncl-1 contains the same motifs as Brat-B-box1, B-box2, coiled-coil, and bpropeller (B1B2CP), and in the same order. In the Cterminus b-propeller domain they are 90% similar. In ncl-1 loss of function mutants, the nucleoli are enlarged and individual cells are larger than wild-type, resulting in larger worms (Hedgecock and Herman, 1995; Frank and Roth, 1998) .
Next is a subgroup of mammalian Brat homologs, including one mouse homolog, one rat homolog, and two human homologs. Although they also have two zinc ®ngers, they are distinguished in having the RING ®nger and the B-box2 motif, in addition to the common coiled-coil and bpropeller motifs (RB2CP). The relative order of the zinc ®ngers, the coiled-coil, and the b-propeller domain is always the same. The human KIAA0517 is a protein with unknown function identi®ed through random sequencing of large protein-coding sequences from the brain. The mouse HAC1 is a novel protein with an unknown function. The rat BERP was cloned recently and was shown to interact with myosin V and aactinin-4 suggesting a role for BERP in myosin Vmediated cargo transport or in anchoring class V myosin to speci®c cell domains via its interaction with a-actinin-4 (El- Husseini and Vincent, 1999; El-Husseini et al., 2000) . BERP shares 99% identity with the mouse HAC1. The human BERP was cloned by its similarity to the rat BERP (El-Husseini and Vincent, 1999) , and they are 98% identical. KIAA0517 is 66% identical to human BERP, and 67% to the mouse HAC1 and the rat BERP (Figure 4a ). Another subgroup includes F54G8.4, a nematode ORF with unknown function, and the human HT2A protein, identi®ed through its interaction with the human immunode®ciency virus protein Tat (Fridell et al., 1995) . Here the RING ®nger is accompanied by Bbox1, namely a composition of RB1CP. Finally, a subgroup with the composition of RB1B2CP, containing all three zinc ®ngers ± the RING ®nger and both B-boxes, was also found. These are the Drosophila AF145661, and the nematode F26F4.7 and C12C8.3, Brat-like ORFs with unknown function.
The nature of brat mutations
To learn about the contribution of the dierent functional domains to Brat tumor suppression activity, we sequenced several brat alleles. Interestingly, all of them were mutated in the b-propeller domain ( Figure  4b) , the b-propeller domain is deformed by non-conservative point mutations that lead to a change in two conserved amino acids: glycine in position 860 to aspartic acid in the ®rst case, and histidine in position 802 to leucine in the latter (Figure 4b ). Apparently, this protein motif involved in the tumor suppression activity of brat.
Brat gene expression
Northern blot analysis of adult poly(A) RNA revealed one transcript, about 6 kb long ( Figure 5 ). A 7.5 kb transcript was also detected in 0 ± 24 h embryonic total RNA (data not shown). It is not known how these transcripts correlate with the two alternative mRNAs described above. In adult poly(A) RNA preparation from a homozygous strain of an imprecise excised transposon in brat K06028 , a larger transcript, about 8.0 kb long, was detected ( Figure 5 ). Sequence analysis established that in this strain, the wild-type phenotype was rescued after excision of all but 1715 bp of the 10.6 kb long inserted transposon. The resulting transcript is still longer than the wild-type brat transcript, Slack and Ruvkun, 1998) , residues conserved in Brat are shown in black, non-conserved residues are shown in grey, and h represents the hydrophobic residues isoleucine, leucine and valine but it is much shorter than the putative brat transcript produced in the brat K06028 strain and, apparently, it does not interfere anymore with the normal Brat activity.
brat is expressed in the embryonic CNS and PNS To investigate the expression of brat during embryogenesis, RNA in situ hybridization was performed on whole mount embryos at dierent developmental stages (Figure 6a ± i). In parallel, we stained embryos from strain brat
K06028
, carrying the P-lacW transposon, with anti b-galactosidase antibody (Figure 6j ± t). This transposon sits in the untranslated exon 4 of brat (Figure 2a) , and it carries a bacterial b-galactosidase gene fused to the P-element transposase, under the control of the transposase promoter (Bier et al., 1989) . We suspected that this transposon can be utilized as a brat enhancer trap (Bellen et al., 1989; Bier et al., 1989) , namely that the b-galactosidase expression mimics brat expression due to the activity of nearby putative brat enhancer elements.
Our results showed that the major site of brat expression throughout embryonic development are the nervous tissues, namely the developing brain, the ventral central nervous system (CNS), and the peripheral nervous system (PNS). No brat transcripts or bgalactosidase activity were detected in these tissues until stage 11 (Figure 6j ,k; not shown for the RNA in situ hybridization experiment). Low level of brat expression was ®rst detected at late stage 12 embryos in the developing brain and ventral CNS, and in the developing PNS (Figure 6a,l) . By stage 13, moderate levels of brat were observed in the brain, and in the ventral CNS ganglion mother cells as well as in the dierentiating sensilla (Figure 6b,m) . As development of the embryonic brain, ventral CNS, and PNS proceeds, brat expression at these sites became more intense (stages 14 to 17; Figure 6c ± g,n ± r). Higher magni®ca-tion of stage 16 embryos reveals that brat is expressed in the four various clusters of the peripheral neurons, containing the dorsal (d), lateral (l), and both ventral (v and v') clusters (Figure 6i ,t; Cluster v is not shown). The dorsal cluster contain the external sensilla (mechanoreceptors and chemoreceptors), and the lateral cluster contains the chordotonal organs (stretch receptors).
Higher magni®cation of the ventral nerve cord of stage 16 embryos revealed that brat is expressed in the ganglion mother cells (Figure 6h,s) . Some neuroblasts, that are similar in size to the ganglion mother cells at this stage, might be stained as well. In addition, brat expression was detailed in cells of the antennomaxillary complex (amx) that comprising the antennal and maxillary sensory organs (Figure 6g,p) . We also observed in brat K06028 embryos a distinct b-galactosidase expression in the cardioblasts (cb) that form the dorsal vessel (dv) through which the hemolymph circulates. These cells were stained in embryos during dorsal vessel development starting at late stage 11 (Figure 6k ) and they persisted until dorsal closure at stage 17. We could not detect a similar staining in the RNA in situ hybridization experiment. This dierence may be due to insucient sensitivity of this technique in observing low levels of transcripts in a relatively small number of cells.
brat expression in the third instar larva As described above, staining for b-galactosidase activity in the enhancer trap line brat k06028 is similar to the pattern obtained by direct detection of brat transcripts using brat anti-sense RNA. Thus, this line was used to detect the spatial distribution of brat expression in the third instar larva. In this experiment we used X-gal staining to detect b-galactosidase activity. This staining is mostly nuclear due to the nuclear localization signal of the transposase-b-galactosidase fused protein (Bier et al., 1989) . In the heterozygous normal brain, the inner region of the brain hemispheres was stained (Figure 7a ). This region contains a core of the larval neuropile and surrounding larval neurons and supporting glia cells. It is dicult to decide distinctly which cells were stained, but the scattered painted pattern suggests that these are probably the glia cells. In any case, the outer region of the brain hemispheres, containing the presumptive adult optic centers, was clearly not stained. Residing in this region are the neuroblasts and the ganglion mother cells that transformed into neoplastic cells in brat mutant brains. Apparently, normal brat activity is not required in these cells at this stage, and therefore the lack of this activity in the mutant cells cannot be the reason for their transformation. Thus, the critical phase of brat activity is not in the third instar larva, but earlier, probably in the embryo, as suggested also for mbt and lgl (Gate et al., 1993; Strand et al., 1994a; see Discussion) . In the mutant brain, presented in the same magni®cation as the wild type brain, the proliferating neoplastic neuroblasts and ganglion mother cells invaded the region of the glia stained cells such that they are dispersed all over the brain (Figure 7b) . In both the normal and mutant strains, the ventral ganglion is normal. The two sides of the thoracic part are stained (Figure 7a ; not shown for the mutant line). The two sides of the abdominal parts are also stained but to a less extent. The imaginal discs were generally not stained (Figure 7a,b) , except single cells of the peripheral nervous system (not shown). In addition to the CNS, two glands were found to express brat. The ring gland was completely stained (Figure 7c ) while in the salivary glands only the proximal tips containing the imaginal rings, the anlagen of the adult salivary glands, were stained (Figure 7d) . Finally, two parts of the foregut were also stained. These include the whole length of the gastric caecaes (Figure 7e) , and the posterior third region of the proventriculus (Figure 7f ). In sum, brat is expressed in several tissues and organs, namely organs of the nervous system, secreting glands, and parts of the digestive system, all of them may be classi®ed as transporting and secreting tissues. 
Cloning the brat gene
Mutations in any one of at least four tumor suppressors involved in Drosophila brain neoplasm are known: disc large (dlg), lethal giant larvae (lgl), malignant brain tumor (mbt), and brain tumor (brat). Until now, all but brat were cloned. To ascertain unambiguous identi®cation of the brat gene we cloned it from two brat P-lacW strains by the plasmid rescue approach. It should be noted that several years ago a set of sequences were cloned by chromosomal walk and assigned to the brat gene (G Hankins, PhD thesis, 1991). Our sequence comparison analysis indicates that those sequences are a subset of the brat locus. In addition to the veri®cation protocol used by the Berkeley Drosophila Genome Project (Spradling et al., 1999) , our data strongly support the identi®cation of this locus with the brat mutation: ®rst, excision of the P-lacW transposon in the brat K06028 strain restores the wild-type phenotype; and second, four alleles of brat were completely sequenced and found to be mutated in the coding sequence, two of them are predicted to encode for truncated proteins.
Three protein-binding motifs in the brat protein
The largest ORF of the Drosophila brat gene encodes for an 1037 amino acid protein with two N-termini zinc ®ngers previously described as B-box motifs, a coiled-coil region and a C-terminus b-propeller domain. The B-box motifs, which have been found in several oncoproteins such as PML, RET, and T18 (Reddy et al., 1992) , were shown to bind one zinc atom and are likely to represent sites of protein ± protein interactions . Proteins of the Ring ®nger/B-box/Coiled-Coil (RBCC) group contain highly conserved zinc-binding RING ®nger and one or two zinc-binding B-box domains, followed by a coiled-coil domain (Reddy et al., 1992; Saurin et al., 1996) . Brat represents a new subgroup of the Bbox proteins that contains only two B-box domains followed by a coiled-coil domain without the RING ®nger. The Brat coiled-coil domain was detected by the coils protein analysis programs (Lupas, 1997) . Coiled-coils ful®ll a variety of functions: they form large, mechanically rigid structures, such as hair, scales and feathers or blood clots, the cellular skeleton, molecular stalks (e.g. kinesin) and levers (e.g. myosin). They provide a scaold for regulatory complexes, and they involve dynamic motions and rearrangements (Lupas, 1996) . However, mutations in the RING ®nger, B-box domains and the coiled-coil region of the PML protein aect nuclear body formation in vivo, suggesting that the RING ®nger, B-box type 1 and 2 and the subsequent coiled-coil domain are an integrated structural unit, perhaps involved in protein oligomerization .
The b-propeller domain consists of six repeats of the NHL motif (Slack and Ruvkun, 1998) . The NHL repeats contain four b-strands separated by loops and are predicted to form a circular b-propeller fold with six blades, similar to that described for proteins containing WD-repeats (Rost et al., 1997; Springer, 1998) .
The b-propeller domain is essential for the tumor suppressor activity of Brat Sequencing of four brat alleles disclosed mutations only in the b-propeller domain, including two stop codons and two non-conservative amino acid changes (Figure 4b) . Two of the strongest alleles, brat 11 and brat
14
, code for C-terminus proteins truncated at the bpropeller domain. In two weaker alleles, brat ts1 and brat fs3 , the b-propeller domain is also mutated by amino acid replacement in residues G860 and H802, respectively. Interestingly, the relative location of these two mutations in the predicted b-propeller 3D structure is the same. Residue G860 is predicted to be the ®rst amino acid located N-terminal to b strand 2d while residue H802 is predicted to be the ®rst amino acid located N-terminal to b strand 1c (Figure 3c ). These mutations in the ®rst two blades of the bpropeller domain suggest that the groove between them may be a binding site to a protein that is crucial for normal Brat function. Furthermore, the strongest alleles, brat 11 and brat
, code for Brat protein lacking most of its b-propeller blades, including all of blade 2 and most of blade 1. It was postulated for the clathrin protein that pairs of its b-propeller blades may be relatively independent of the rest of the domain and can specialize in order to recognize particular partners (ter Haar et al., 1998) . These may suggest that the brain tumor phenotype of the Drosophila larvae might be the result of mutations aecting the interaction of a speci®c protein with blades 1 and 2 of the Brat bpropeller domain. The clustering of mutations in this domain strongly suggests a crucial role for this region, and for proteins that interact with it, in the tumor suppression activity of Brat.
None of the known brat mutations can be de®ned as a true null mutation, but the recessive nature of these mutations suggests that they represent loss-of-function mutations. For example, mutations in the b-propeller domain are not the only path that might lead to neoplastic brat brains. As described above, the two Pelement in strains brat K11523 and brat K06028 also display the brat phenotype although the transposons are inserted at intron IB and the non-coding exon 4, respectively (Figure 2a) . The exact reason for the mutant phenotype in these cases is not known. Presumably it is due to replication and transcription regulatory sequence elements found in these transposons that may interfere with RNA transcription and splicing or with the protein translation machineries, ultimately ending up in lower concentration and hence lower activity of the brat gene product. Alternatively, the insertion of relative large-sized transposons, 10.6 kb long, results in the addition of a substantial chunk of RNA to the primary transcript in the case of brat
K06028
, and to the processed mRNA in the case of brat
. These changes might also interfere with normal functions, causing a mutated phenotype.
Indeed, overexpressing the N-terminal region of BERP, the brat human homolog, in PC12 cells, prevents dominantly their dierentiation after NGF stimulation (see below). However, since this region is required for BERP dimerization (El-Husseini and Vincent, 1999) , the truncated BERP may have a dominant-negative eect that also results in the loss of BERP function.
Oncogene brat, a Drosophila brain tumor suppressor E Arama et al The temporal and spatial pattern of b-galactosidase expression in the enhancer trap line is identical to the brat transcription pattern in the developing embryos revealed by the RNA in situ hybridization experiment (compare a ± l, b ± m, c ± n, e ± p, g ± r, h ± s, and i ± t). No b-galactosidase expression was detected in the precursors of the brain, CNS, and PNS in early embryos at stages 9, and 11 (j and k, respectively), and it is ®rst expressed in stage 12 in the brain, CNS, and PNS (l). Stronger expression is seen in the next stages, 13 to 17 (m ± r). (s,t) Higher magni®cation of CNS and PNS, respectively, from stage 16 embryos. In the PNS, staining was detected in the four various clusters: dorsal, lateral, and two ventral clusters (t; the second brat, a Drosophila brain tumor suppressor E Arama et al
The Brat protein family
Proteins similar to Brat are found from the nematode to human (Figure 4a ). All of them carry the three functional domains but vary in the number and type of the zinc-®ngers elements. Two members of the Brat protein family were investigated in some detail. The nematode Ncl-1 protein is highly similar to Brat, particularly in its C-termini b-propeller domain where the similarity reaches 90%. In ncl-1 loss of function mutants, the nucleoli are enlarged and individual cells are larger than wild-type, resulting in larger worms (Hedgecock and Herman 1995) . Ncl-1 was proposed to function as a general repressor of cell growth, via repression of ribosomal RNA synthesis (Frank and Roth 1998). Interestingly, tumor cells often have enlarged nucleoli (Smetana et al., 1970; Derenzini and Terere, 1991) . In this regard it should be noted that ventral cluster is out of frame). A speci®c and restricted expression of b-galactosidase was detected also in cardioblasts throughout the embryonic dorsal vessel development (k ± r). Abbreviations: co, commissures sites; cn, connective sites; pns, peripheral nervous system sensilla cells; br, brain hemispheres; vnc, ventral nerve cord; amx, antennomaxillary complex; dv, dorsal vessel; d, dorsal cluster; l, lateral cluster; v, dorsally ventral cluster. The numbers at the bottom and left corner of each picture indicate the embryonic stage. The calibration bars in (a) and (j) indicate 100 mm, and (a ± g) and (j ± r) are of the same magni®cation. In (h) and (s) the bars indicate 50 mm, and (h,i,s) and (t) are of the same magni®cation 
increase in RNA polymerase I and III transcriptional activity (Nasmyth, 1996; White et al., 1996; Larminie et al., 1997; Cairns and White, 1998) . It is possible that one way in which tumor cells are able to achieve an increase in cell growth is by increasing their ability to synthesize proteins through mutation of genes such as Rb and p53 that normally function to repress RNA polymerase I and III transcription (for review see Nasmyth, 1996; Larminie et al., 1998; White, 1997) . The phenotype of ncl-1, namely enlarged nucleoli and larger cells, was not observed in brat mutants, suggesting that if Ncl-1 and Brat function along similar processes, their targets could be dierent.
The rat brat homolog BERP interacts with the Myosin-V protein through its b-propeller domain (ElHusseini and Vincent, 1999) . In yeast, myosin V seems to play a speci®c role in the vectorial transport of secretory vesicles necessary for the localization of bud initiation and formation. In rats, myosin V has a role in organelle transport along the axon and at the nerve terminal (Larson, 1996) . The RING ®nger/B-box/ coiled-coil (RBCC) domain of BERP is required for BERP dimerization, and for binding with a-actinin-4, a non-muscle calcium-insensitive actinin (El-Husseini et al., 2000) . Upon administration of nerve growth factor (NGF), PC12 cells normally start dierentiating; they stop dividing and develop neurite outgrowth. However, overexpression of the RBCC domain of BERP suppresses this phenomena and the cells continue proliferating, suggesting that the BERP-myosin interaction is essential for NGF-mediated dierentiation of PC12 cells. COP1 is a photomorphogenic repressor in Arabidopsis, containing a RING ®nger, a coiled-coil domain, and a b-propeller domain, but no B-box. Expression of a truncated COP1 lacking the bpropeller domain resulted in a dominant-negative phenotype in transgenic plants (McNellis et al., 1996) . Interestingly, mutations in the b-propeller domain of Brat also result in the blocking of dierentiation in the larval brain, and overproliferation of neuroblasts and ganglion mother cells.
Expression of brat during development
While brat is expressed intensely in all parts of the embryonic nervous system (Figure 6 ), its expression is delayed until stage 12. During stages 9 to 13, neuroblast in the brain and ventral CNS undergo eight waves of mitosis yielding their progeny called ganglion mother cells, while sensillum precursors perform two or three divisions during stages 11 and 12, to produce the dierent cells that make up the sensilla (Hartenstein, 1993; Hartenstein et al., 1987) . In both the brain/CNS and the PNS, neuronal cells dierentiation begins at stage 13. In the brain and ventral CNS each ganglion mother cell performs one equal division yielding two postmitotic neurons, whereas in the PNS the ®rst wave of sensilla starts to dierentiate. brat is not expressed in precursors of the brain and ventral CNS, namely the mitotically dividing neuroblasts (stages 9 onward), nor in dividing PNS sensillum precursors (stages 11 onward). Since the initiation of brat expression in the embryo is concomitant with the onset of neuronal cell dierentiation, it is plausible to suggest that it is expressed in any of the new cell types appears during stage 12, namely the ganglion mother and postmitotic neurons in the developing CNS, and dierentiating sensilla cells in the developing PNS.
To learn about brat expression in postembryonic stages we looked at the staining of the enhancer trap line in third instar larva. brat is expressed in several transporting/secreting tissues and organs (Figure 7 ) such as the nervous system (the brain and the ventral ganglion), two glands (the ring and salivary glands), and the gut (the gastric caecae and the proventriculus). As described above, myosin V, which mediates the function of the human brat homolog, BERP, also participate in transport of secreted vesicles in yeast and in vectorial transport in nerve cells in mammals (ElHusseini and Vincent, 1999) .
When the tumor suppressor activity of brat is required?
The pattern of the staining in the larval brain is intriguing, since the region of the presumptive adult optic center is clearly not stained. However this region contains the neuroblasts and ganglion mother cells that overproliferative in brat mutated brains, implying that this is not the absence of the normal brat activity in this stage that induces the neoplastic growth of these cells in the mutant brain. Thus, the tumor suppressor activity of brat may be required not in the larval tumor cells, but probably as early as the embryonic stage, where the fate of these cells is determined. This hypothesis is supported by a line of evidence obtained in experiments with two other Drosophila brain tumor suppressors, mbt and lgl, summarized herein: (a) Shiftup and shift-down experiments with a temperature sensitive allele of mbt revealed that the temperature sensitive period of mbt activity responsible for brain tumor suppression encompasses the ®rst 6 h of embryonic development (Gate et al., 1993) ; (b) The lgl protein is not detected in the second and early third instar larval brain, when the ®rst abnormalities are visible in the mutant brain. However, it is expressed in the embryonic CNS (Strand et al., 1994a) ; (c) Transplantation of embryonic tissues from lgl mutated embryos revealed that these tissues have already acquired malignant capacity (Gate and Schneiderman, 1974) . (d) Brain tumors can be developed only from lgl clones produced before blastoderm formation, while lgl clones produced during larval development dierentiate normally (Cline, 1976; Merz et al., 1990) . The molecular nature of this elusive cell fate determination step in the embryo is yet to be studied.
Materials and methods
Fly strains and isolation of viable revertants
The OregonR wild type strain was obtained from the Caltech Drosophila stock center. Strains l(2)K06028 (brat
K06028
) and brat ts1 were obtained from the Bloomington Stock Center, brat fs3 from the Umea Stock Center, and strain l(2)K11523 (brat
K11523
) was obtained from the Szeged Stock Center. brat 11 and brat 14 were obtained from T Wright. To obtain viable revertants the P-lacW transposon was excised from strain l(2)K06028 using the transposase-producing D2-3`jumpstart' strain (Robertson et al., 1988) , essentially as described (ToÈ roÈ k et al., 1993). . These fragments were sequenced (Biological Services, Weizmann Institute of Science) and used to search public databases. Two matching EST sequences, LD28374 and LD16270, were identi®ed using both 5' and 3'-¯anking sequences of the insertion in brat K06028 , respectively, and the latter EST clone was completely sequenced. Screening again against the sequence of LD16270 identi®ed two new ESTs, GM0133 and GM05115.
To identify the 5'-end of the gene, the 5'-end of LD16270 was used as a probe to screen a 9 ± 12-h embryonic cDNA library (kindly provided by K Zinn). More than 30 cDNAs were detected and four cDNA clones, Bt4, 11, 12, and 29, were completely isolated and sequenced. Searching the Drosophila genomic database against the assembled cDNA sequences of the gene identi®ed two BAC clones, DS04472 and BACR48O01 (GenBank Accession Number AC007176) that together include the entire brat locus. The brat gene sequence is published under GenBank Accession Number AF119332.
Sequencing of brat mutated alleles
To identify homozygous progeny for each of the brat alleles 11, 14, ts1 and fs3, we prepared brat 11 , brat
14
, brat ts1 and brat fs3 stocks in which the brat allele was balanced with a green¯uorescent protein (GFP)-expressing balancer (obtained from the Bloomington Drosophila Stock Center). For each of the four alleles examined 25 non-¯uorescing, and therefore homozygous, third instar larvae were collected under a¯uorescent microscope and subjected to a genomic DNA puri®cation (High Pure PCR Template Preparation Kit, Boehringer Mannheim). Two mg of genomic DNA were used to amplify the brat coding region in a PCR reaction. To obtain ecient data collection we used long PCR fragments and direct sequencing of PCR products, without cloning. Two partially overlapping PCR fragments, 2819 and 1311 bp long, were designed covering all brat coding region. The pairs of primers used were: GTTGGCACAGGAAGCATT and CCTCCATCACGCCGAATT; GAGACTTCTGCTGAGC-GGT and CCGCGCAAGTCAGACTATT. PCR reaction was carried out using DyNAzyme EXT DNA polymerase, according to the manufacturer instructions (Finnzymes). PCR cycles were: 1 min at 948C, and then 1 min at 608C, 3.5 min at 708C, and 20 s at 938C for 26 cycles. The products were puri®ed (High Pure PCR Product Puri®cation Kit, Boehringer Mannheim), concentrated by evaporation, and sequenced using an Applied Biosystems Model 373 automated sequencer (DNA Sequencing Unit, Biological Services, Weizmann Institute of Science). Each of the genomic DNA of the brat alleles were ampli®ed twice by independent PCR reactions and used to con®rm the sequence on both strands.
The sequence of the brat alleles 11, 14, ts1, and fs3, is published under GenBank Accession Numbers AF195870, AF195871, AF195872 and AF195873, respectively.
RNA isolation and blotting
Total RNA was extracted by a combination of guanidin thiocyanate/phenol method. Brie¯y, adult¯ies frozen in liquid nitrogen were pounded into powder using a mortar and pestle, and suspended in guanidin thiocyanate (GTC) lysis solution (4 M GTC, 25 mM sodium citrate pH 7.0, 0.5% sarkosyl, 0.1 M b-mercaptoethanol). Larvae were homogenized in lysis solution without freezing. The lysis mixture was extracted with acidic phenol, and RNA was precipitated, resuspended in the lysis solution, and reprecipitated. The average yield was 2 mg RNA per 1 gr starting material. Poly(A) RNA was isolated (Polyatract, Promega) and blotted. Blotting and hybridization with random-primed labeled Brat DNA probe were carried out according to standard protocols.
In situ RNA analysis
In situ hybridization of embryos at dierent stages was carried out as described (Tautz and Pfei¯e, 1989) . The antisense probe was obtained from LD16270, a brat EST cloned in Bluescript SK + (Stratagene). LD16270 was linearized at a BspEI site (569 bp from the 3' edge of the insert including part of the 3'UTR of brat), and RNA was transcribed by T7 RNA polymerase in the presence of digoxigenin-UTP (Bohringer). As a sense control probe, a XbaI-HindIII subclone of LD16270 was similarly labeled after linearization with XhoI (674 bp from the 5' edge of the insert including part of the 5' UTR and the coding region of brat). Stained embryos were cleared with 70% glycerol, mounted, and examined by Nomarski optics on Zeiss Axiophot.
Detection of b-galactosidase activity by immunocytochemistry
To detect b-galactosidase expression in embryos and in larval tissues from brat K06028 carrying the P-lacW transposon, 0 ± 17 h old embryos and dissected larval tissues were collected and processed for whole mount antibody staining using standard techniques (Ashburner, 1989) . Anti b-galactosidase antibody (diluted 1 : 500; Promega) was used as a primary antibody and incubated at 48C overnight. The secondary antibody was a biotinylated horse anti-mouse antibody (Vector). Signal detection was carried out with a VectaStain ABC-HRP kit (Vector). Prior to use, antibodies were preabsorbed to 0 ± 3 h old embryos for 2 h at room temperature or overnight at 48C. Stained tissues and embryos were cleared with 70% glycerol, mounted, and examined by Nomarski optics on Zeiss Axiophot.
Detection of b-galactosidase activity by X-gal staining
Histochemical staining for b-galactosidase activity was carried out on dissected brat K06028 larval tissues, essentially as described (Ashburner, 1989; Salzberg et al., 1993) . Distinction between hetero-or homozygous larvae was carried out using the brat K06028 line carrying the green uoresence protein on the balancer chromosome.
